These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2975097)

  • 1. [Effect of the angiotensin-converting enzyme inhibitor ramipril on proteinuria, blood pressure and kidney function in histologically confirmed glomerulonephritis with nephrotic syndrome].
    Götz R; Drechsler U; Heidbreder E; Heidland A
    Z Kardiol; 1988; 77 Suppl 3():65-8. PubMed ID: 2975097
    [No Abstract]   [Full Text] [Related]  

  • 2. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function.
    Tillman DM; Adams FG; Gillen G; Morton JJ; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):133D-142D. PubMed ID: 3034022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
    Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
    Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
    Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
    Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO; van Baak MA; Rahn KH
    Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.
    Kindler J; Schunkert H; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Ritz E; Sieberth HG
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S55-8. PubMed ID: 2474105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.
    Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K
    Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension.
    Kaneko Y; Omae T; Yoshinaga K; Iimura O; Inagaki Y; Ishii M; Saruta T; Yamada K; Kumahara Y; Ito K
    Am J Cardiol; 1987 Apr; 59(10):86D-91D. PubMed ID: 3034040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
    Thaiss F; Haas C; Helmchen U; Wenzel U; Stahl RA
    Nephrol Dial Transplant; 1996 Jan; 11(1):40-6. PubMed ID: 8649651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
    Karlberg BE; Lindström T; Rosenqvist U; Ohman KP
    Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG; Ganten D; Lang RE; Unger T
    J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of ramipril.
    Ball SG; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term effects of ramipril in hypertension.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ramipril on 24-hour variability of blood pressure and heart rate in essential hypertension.
    Tochikubo O; Asahina S; Kaneko Y
    Am J Cardiol; 1987 Apr; 59(10):83D-85D. PubMed ID: 3034039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.
    Iodice C; Balletta MM; Minutolo R; Giannattasio P; Tuccillo S; Bellizzi V; D'Amora M; Rinaldi G; Signoriello G; Conte G; De Nicola L
    Kidney Int; 2003 Jun; 63(6):2214-21. PubMed ID: 12753310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
    Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
    Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension.
    Felder K; Witte PU
    Arzneimittelforschung; 1984; 34(10B):1452-4. PubMed ID: 6097273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril.
    Predel HG; Düsing R; Bäcker A; Kipnowski J; Kramer HJ
    Am J Cardiol; 1987 Apr; 59(10):143D-148D. PubMed ID: 3034023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.